Severity
Moderate
FDA Drug recall · Reported February 12, 2014
Lack of Assurance of Sterility: The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes identified during a…
Apothecure, Inc recalled The firm is recalling all lots of sterile products compounded by the pharmacy that are wi… — a moderate-severity action.
The firm is recalling all lots of sterile products compounded by the pharmacy that are wi… was recalled by Apothecure, Inc in February 12, 2014. Reason: Lack of Assurance of Sterility: The recall is being initiated due to the lack of sterility assurance and conc…. Check the official notice for the remedy. Verify recall #D-1066-2014 with the FDA Drug before acting.
The recall
Apothecure, Inc issued this moderate-severity FDA Drug recall — Lack of Assurance of Sterility: The recall is being initiated due to the lack of sterility assurance and conc….
Sourced from official FDA Drug enforcement records. Verify recall #D-1066-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1066-2014) was formally reported on February 12, 2014, with the manufacturer initiating the action on April 15, 2013. It is classified under Moderate severity (Class II), with a current status of Terminated. Apothecure, Inc is listed as the recalling firm, operating out of Dallas, TX. The number of affected units is not disclosed in the agency filing, which is common for drug and food recalls where lot-level tracking supersedes unit counts.
The documented reason for this recall is: Lack of Assurance of Sterility: The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection. Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug — clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category — 14,048 drugs & medications recalls on record
Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger — we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
Unknown
Related Recalls
6
5 from same agency
The firm is recalling all lots of sterile products compounded by the pharmacy that are within expiry.
Lack of Assurance of Sterility: The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-1066-2014 |
| Date reported | February 12, 2014 |
| Date initiated | April 15, 2013 |
| Recalling firm | Apothecure, Inc |
| Firm location | Dallas, TX |
| Affected scope | Not disclosed |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Keep tracking product safety across the federal recall archive.
Recall Checker
Search the full archive by product name, brand, or recall number across every agency.
Check a product →
FDA Drug recalls
Every recall issued by FDA Drug, newest first.
Browse the feed →
RecallRadar
Live feed of the latest recalls across the FDA, CPSC and NHTSA — filter by agency and severity.
View the live feed →
Rankings
The largest recalls by units affected and the most-recalled product categories.
See the rankings →
Browse by category
Find recalls by product type to spot recurring defect patterns.
All categories →
What to do next
A step-by-step guide to refunds, repairs, and returns after a recall.
Read the guide →
Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.
AVEVA Drug Delivery Systems, Inc. · 2026-06-03
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Compare this recall with Nicotine Transdermal System Patch, 14 mg, 14 patches per bo… →
Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Drug, reported February 12, 2014.
Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records — no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.